CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial
Trials - United Kingdom
doi 10.1186/s13063-018-2602-y
Full Text
Open PDFAbstract
Available in full text
Date
April 18, 2018
Authors
Publisher
Springer Science and Business Media LLC